WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
2010
2.2K+
LTM Revenue $736M
LTM EBITDA $94.6M
$975M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
WELL Health has a last 12-month revenue of $736M and a last 12-month EBITDA of $94.6M.
In the most recent fiscal year, WELL Health achieved revenue of $543M and an EBITDA of $78.1M.
WELL Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See WELL Health valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $543M | $692M | XXX | XXX | XXX |
Gross Profit | $108M | $212M | XXX | XXX | XXX |
Gross Margin | 20% | 31% | XXX | XXX | XXX |
EBITDA | $78.1M | $89.1M | XXX | XXX | XXX |
EBITDA Margin | 14% | 13% | XXX | XXX | XXX |
Net Profit | -$30.6M | $1.0M | XXX | XXX | XXX |
Net Margin | -6% | 0% | XXX | XXX | XXX |
Net Debt | $195M | $174M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, WELL Health's stock price is CAD 4 (or $3).
WELL Health has current market cap of CAD 1.1B (or $744M), and EV of CAD 1.4B (or $975M).
See WELL Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$975M | $744M | XXX | XXX | XXX | XXX | $0.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, WELL Health has market cap of $744M and EV of $975M.
WELL Health's trades at 1.3x LTM EV/Revenue multiple, and 10.3x LTM EBITDA.
Analysts estimate WELL Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for WELL Health and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $975M | XXX | XXX | XXX |
EV/Revenue | 1.4x | XXX | XXX | XXX |
EV/EBITDA | 10.9x | XXX | XXX | XXX |
P/E | 25.9x | XXX | XXX | XXX |
P/E/Growth | -2.2x | XXX | XXX | XXX |
EV/FCF | 16.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpWELL Health's NTM/LTM revenue growth is 19%
WELL Health's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, WELL Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate WELL Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for WELL Health and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 28% | XXX | XXX | XXX | XXX |
EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
EBITDA Growth | 14% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 32% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 27% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 44% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
WELL Health acquired XXX companies to date.
Last acquisition by WELL Health was XXXXXXXX, XXXXX XXXXX XXXXXX . WELL Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was WELL Health founded? | WELL Health was founded in 2010. |
Where is WELL Health headquartered? | WELL Health is headquartered in Canada. |
How many employees does WELL Health have? | As of today, WELL Health has 2.2K+ employees. |
Who is the CEO of WELL Health? | WELL Health's CEO is Mr. Hamed Shahbazi. |
Is WELL Health publicy listed? | Yes, WELL Health is a public company listed on TSE. |
What is the stock symbol of WELL Health? | WELL Health trades under WELL ticker. |
When did WELL Health go public? | WELL Health went public in 2012. |
Who are competitors of WELL Health? | Similar companies to WELL Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of WELL Health? | WELL Health's current market cap is $744M |
What is the current revenue of WELL Health? | WELL Health's last 12-month revenue is $736M. |
What is the current EBITDA of WELL Health? | WELL Health's last 12-month EBITDA is $94.6M. |
What is the current EV/Revenue multiple of WELL Health? | Current revenue multiple of WELL Health is 1.3x. |
What is the current EV/EBITDA multiple of WELL Health? | Current EBITDA multiple of WELL Health is 10.3x. |
What is the current revenue growth of WELL Health? | WELL Health revenue growth between 2023 and 2024 was 28%. |
Is WELL Health profitable? | Yes, WELL Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.